Recombinant multi-species ALDH1A2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ALDH1A2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This protein belongs to the aldehyde dehydrogenase family of proteins. The product of this gene is an enzyme that catalyzes the synthesis of retinoic acid (RA) from retinaldehyde. Retinoic acid, the active derivative of vitamin A (retinol), is a hormonal signaling molecule that functions in developing and adult tissues. The studies of a similar mouse gene suggest that this enzyme and the cytochrome CYP26A1, concurrently establish local embryonic retinoic acid levels which facilitate posterior organ development and prevent spina bifida. Four transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, May 2011]
The Alternative Names of target: ALDH1A2,Aldehyde dehydrogenase family 1 member A2 (ALDH1A2),Aldh1a2,Aldh1a7,DIH4,RALDH 2,RALDH(II),RALDH2,RALDH2-T,RalDH2,Raldh-2,Raldh1,Raldh2,Retinal dehydrogenase 2,Retinaldehyde-specific dehydrogenase type 2 (RALDH(II))

Target products collectionGo to ALDH1A2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP13292-Ag-1/ GM-Tg-hg-IP13292-Ag-2 Human ALDH1A2 protein Human
GM-Tg-rg-IP13292-Ag-1/ GM-Tg-rg-IP13292-Ag-2 Rat ALDH1A2 protein Rat
GM-Tg-mg-IP13292-Ag-1/ GM-Tg-mg-IP13292-Ag-2 Mouse ALDH1A2 protein Mouse
GM-Tg-cynog-IP13292-Ag-1/ GM-Tg-cynog-IP13292-Ag-2 Cynomolgus/Rhesus macaque ALDH1A2 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP13292-Ag-1/ GM-Tg-felg-IP13292-Ag-2 Feline ALDH1A2 protein Feline
GM-Tg-cang-IP13292-Ag-1/ GM-Tg-cang-IP13292-Ag-2 Canine ALDH1A2 protein Canine
GM-Tg-bovg-IP13292-Ag-1/ GM-Tg-bovg-IP13292-Ag-2 Bovine ALDH1A2 protein Bovine
GM-Tg-equg-IP13292-Ag-1/ GM-Tg-equg-IP13292-Ag-2 Equine ALDH1A2 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP13292-Ag-1/ GM-Tg-hg-IP13292-Ag-2; GM-Tg-rg-IP13292-Ag-1/ GM-Tg-rg-IP13292-Ag-2;
GM-Tg-mg-IP13292-Ag-1/ GM-Tg-mg-IP13292-Ag-2; GM-Tg-cynog-IP13292-Ag-1/ GM-Tg-cynog-IP13292-Ag-2;
GM-Tg-felg-IP13292-Ag-1/ GM-Tg-felg-IP13292-Ag-2; GM-Tg-cang-IP13292-Ag-1/ GM-Tg-cang-IP13292-Ag-2;
GM-Tg-bovg-IP13292-Ag-1/ GM-Tg-bovg-IP13292-Ag-2; GM-Tg-equg-IP13292-Ag-1/ GM-Tg-equg-IP13292-Ag-2
Products Name ALDH1A2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ALDH1A2
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ALDH1A2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.